Opinion: TSMC Is a Better Buy Than Any of the "Magnificent Seven" Stocks Right Now

TSMC is cited as outperforming the Magnificent Seven with nearly 36% YTD gains and 78% over the last 12 months, as it benefits from AI-driven chip demand. Q2 revenue rose 33.7% YoY to $40.2B, with gross margin at 67.7% and net profit margin at 55.6%. The article highlights that 2-nanometer production began in Q2 (3% of wafer revenue initially) and that TSMC is expanding U.S. capacity with a further $100B Arizona investment (total Arizona investment: $265B).

Analysis

TSMC is the clearest “sell shovels to everyone” expression of the AI buildout: the more hyperscalers fragment compute into custom ASICs, CPUs, and accelerators, the more wafer demand consolidates at the foundry layer. That is a subtle but important shift versus the market’s usual focus on chip designers; over time it can cap the pricing power of any single accelerator vendor while extending TSMC’s utilization, mix, and bargaining leverage. The second-order winners are the upstream equipment and process ecosystem (AMAT/LRCX/KLA/ASML) and advanced packaging suppliers, because every node transition and design variant increases process complexity, not just volume.

The near-term risk is that the market extrapolates the current AI capex wave too linearly. In the next 1-3 months, the key catalyst is not narrative but whether hyperscaler spending stays elevated and whether TSMC’s advanced-node mix ramps without yield slippage; a single cautionary comment on utilization or capex absorption would hit the stock harder than headline revenue growth. Over 6-18 months, Arizona capex and 2nm depreciation can compress incremental ROIC even if reported gross margin stays high, so the bear case is that the business becomes more capital-intensive just as investors are paying up for scarcity.

Contrarian view: consensus may be underpricing how much of TSMC’s moat is operational, not strategic. If AI workloads migrate toward more inference-efficient architectures or customer self-sufficiency, TSMC still wins, but the multiple may stop expanding once the market realizes it is buying a manufacturing utility with geopolitical risk, not a pure software-like compounder. The thesis is falsified if 2nm ramps slowly, if advanced-node revenue mix stalls, or if capex guidance implies a materially lower free-cash-flow conversion than the market is currently modeling.

Key Decisions for Investors

• Long TSM / short SOXX for 3-6 months: express the view that foundry scarcity and node leadership matter more than broad semiconductor beta; target relative outperformance if AI capex remains firm, and cover if TSM underperforms the basket after the next earnings update.
• Prefer TSM over NVDA on a relative basis into the next two quarters: NVDA remains the demand engine, but TSM monetizes every customer architecture shift; the pair works best if custom silicon adoption continues and accelerator pricing power normalizes.
• Add AMAT, LRCX, and KLA on weakness as second-order beneficiaries: if TSM’s 2nm ramp is real, the process-intensity uplift should pull through equipment orders with a longer lag than the stock reaction, creating a 6-12 month earnings tailwind.
• Use TSM on 3-5% pullbacks rather than chasing strength: the setup is attractive, but the trade is vulnerable to any guidance that implies faster capex growth than free-cash-flow growth.
• Watch for a 2nm/yield or capex-absorption miss as the main falsifier; if management signals a slower-than-expected mix shift or lower ROIC from U.S. expansion, reduce the position immediately.